An Assessment of the Glyconutrient Ambrotose™ on Immunity, Gut Health, and Safety in Men and Women

Completed · Not applicable · Has a placebo group

Conditions studied: Healthy

In brief

This study evaluates the impact of two Ambrotose products on immunity, gut health, and associated measures in healthy men and women. Subjects are randomly assigned in double-blind manner to one of five conditions: 1) 2 grams Advanced Ambrotose, 2) 4 grams Advanced Ambrotose, 3) 2 grams Ambrotose LIFE, 4) 4 grams Ambrotose LIFE, or 5) placebo. Subjects ingested their assigned condition daily for eight weeks.

Key facts

Study ID

NCT04386226

Run by

University of Memphis

People needed

75

Starts

2018-08-15

Expected to finish

2019-06-01

Last updated by the study team

2021-04-28

Who can join

Age: 20 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• must be physically active by participating in structured exercise at least twice per week for 30 or more minutes per session;
• not be pregnant

You may not qualify if…

• diagnosed cardiovascular disease
• diagnosed metabolic disease
• diagnosed neurological disease
• using nutritional supplements or medications known to impact immunity or gut health

Where it is running

• Center for Nutraceutical and Dietary Supplement Research — Memphis, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.